Wheat germ cell-free technology for accelerating the malaria vaccine research

Bibliography

• WHO. World Malaria Report 2008. Geneva, Switzerland: WHO Press; 2008
   Google Scholar
• Miller LH, Baruch DI, Marsh K, The pathogenic basis of malaria. Nature 2002;415:673-9
   PubMed Web of Science ®Google Scholar
• Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006;28:51-60
   PubMed Web of Science ®Google Scholar
• Genton B. Malaria vaccines: a toy for travelers or a tool for eradication? Expert Rev Vaccines 2008;7:597-611
   PubMed Web of Science ®Google Scholar
• Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009;22:13-36, Table of Contents
   PubMed Web of Science ®Google Scholar
• Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192:733-7
   PubMed Web of Science ®Google Scholar
• McGregor IA. The passive transfer of human malaria immunity. Am J Trop Med Hyg 1964;13(Suppl):237-9
   PubMedGoogle Scholar
• Gupta S, Snow RW, Donnelly CA, Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 1999;5:340-3
   PubMed Web of Science ®Google Scholar
• Pombo DJ, Lawrence G, Hirunpetcharat C, Immunity to malaria after administration of ultra-low doses of red cells infected with plasmodium falciparum. Lancet 2002;360:610-7
   PubMed Web of Science ®Google Scholar
• Nussenzweig RS, Vanderberg J, Most H, Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967;216:160-2
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Goh LM, Luke TC, Protection of humans against malaria by immunization with radiation-attenuated plasmodium falciparum sporozoites. J Infect Dis 2002;185:1155-64
   PubMed Web of Science ®Google Scholar
• Roestenberg M, McCall M, Hopman J, Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009;361:468-77
   PubMed Web of Science ®Google Scholar
• Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002;415:670-2
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Nosten F, Yi P, Artemisinin resistance in plasmodium falciparum malaria. N Engl J Med 2009;361:455-67
   PubMed Web of Science ®Google Scholar
• Greenwood B. Can malaria be eliminated? Trans R Soc Trop Med Hyg 2009;103(Suppl 1):S2-5
   PubMedGoogle Scholar
• Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature 2002;415:694-701
   PubMed Web of Science ®Google Scholar
• Greenwood BM, Fidock DA, Kyle DE, Malaria: progress, perils, and prospects for eradication. J Clin Invest 2008;118:1266-76
   PubMed Web of Science ®Google Scholar
• Stoute JA, Slaoui M, Heppner DG, ; RTS,S Malaria Vaccine Evaluation Group. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against plasmodium falciparum malaria. N Engl J Med 1997;336:86-91
   PubMed Web of Science ®Google Scholar
• Heppner DG Jr, Kester KE, Ockenhouse CF, Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 2005;23:2243-50
   PubMed Web of Science ®Google Scholar
• Alonso PL, Sacarlal J, Aponte JJ, Duration of protection with RTS,S/AS02A malaria vaccine in prevention of plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005;366:2012-8
   PubMed Web of Science ®Google Scholar
• Aponte JJ, Aide P, Renom M, Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007;370:1543-51
   PubMed Web of Science ®Google Scholar
• Bejon P, Lusingu J, Olotu A, Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008;359:2521-32
   PubMed Web of Science ®Google Scholar
• Miller LH, Mason SJ, Clyde DF, The resistance factor to plasmodium vivax in blacks. The duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-4
   PubMed Web of Science ®Google Scholar
• Ling IT, Ogun SA, Holder AA. Immunization against malaria with a recombinant protein. Parasite Immunol 1994;16:63-7
   PubMed Web of Science ®Google Scholar
• Perera KL, Handunnetti SM, Holm I, Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human plasmodium vivax malaria. Infect Immun 1998;66:1500-6
   PubMed Web of Science ®Google Scholar
• Crewther PE, Matthew ML, Flegg RH, Protective immune responses to apical membrane antigen 1 of plasmodium chabaudi involve recognition of strain-specific epitopes. Infect Immun 1996;64:3310-7
   PubMed Web of Science ®Google Scholar
• Collins WE, Pye D, Crewther PE, Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of plasmodium fragile. Am J Trop Med Hyg 1994;51:711-9
   PubMed Web of Science ®Google Scholar
• Richards JS, Beeson JG. The future for blood-stage vaccines against malaria. Immunol Cell Biol 2009;87:377-90
   Google Scholar
• Baum J, Maier AG, Good RT, Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog 2005;1:e37
   PubMedGoogle Scholar
• Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell 2006;124:755-66
   PubMed Web of Science ®Google Scholar
• Maier AG, Cooke BM, Cowman AF, Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol 2009;7:341-54
   PubMed Web of Science ®Google Scholar
• Fried M, Duffy PE. Adherence of plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996;272:1502-4
   PubMed Web of Science ®Google Scholar
• Fried M, Nosten F, Brockman A, Maternal antibodies block malaria. Nature 1998;395:851-2
   PubMed Web of Science ®Google Scholar
• Francis SE, Malkov VA, Oleinikov AV, Six genes are preferentially transcribed by the circulating and sequestered forms of plasmodium falciparum parasites that infect pregnant women. Infect Immun 2007;75:4838-50
   PubMed Web of Science ®Google Scholar
• Salanti A, Staalsoe T, Lavstsen T, Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003;49:179-91
   PubMed Web of Science ®Google Scholar
• Viebig NK, Gamain B, Scheidig C, A single member of the plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep 2005;6:775-81
   PubMed Web of Science ®Google Scholar
• Gamain B, Trimnell AR, Scheidig C, Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005;191:1010-3
   PubMed Web of Science ®Google Scholar
• Duffy PE. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology 2007;134:1877-81
   PubMed Web of Science ®Google Scholar
• Feachem R, Sabot O. A new global malaria eradication strategy. Lancet 2008;371:1633-5
   PubMed Web of Science ®Google Scholar
• Carter R. Transmission blocking malaria vaccines. Vaccine 2001;19:2309-14
   PubMed Web of Science ®Google Scholar
• Hisaeda H, Stowers AW, Tsuboi T, Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of plasmodium vivax to infect mosquitoes. Infect Immun 2000;68:6618-23
   PubMed Web of Science ®Google Scholar
• Wu Y, Przysiecki C, Flanagan E, Sustained high-titer antibody responses induced by conjugating a malaria vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci USA 2006;103:18243-8
   PubMed Web of Science ®Google Scholar
• Wu Y, Ellis RD, Shaffer D, Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS ONE 2008;3:e2636
   PubMed Web of Science ®Google Scholar
• Malkin EM, Durbin AP, Diemert DJ, Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for plasmodium vivax malaria. Vaccine 2005;23:3131-8
   PubMed Web of Science ®Google Scholar
• Smith TA, Leuenberger R, Lengeler C. Child mortality and malaria transmission intensity in Africa. Trends Parasitol 2001;17:145-9
   PubMed Web of Science ®Google Scholar
• Targett GA, Greenwood BM. Malaria vaccines and their potential role in the elimination of malaria. Malar J 2008;7(Suppl 1):S10
   PubMed Web of Science ®Google Scholar
• Lasonder E, Ishihama Y, Andersen JS, Analysis of the plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002;419:537-42
   PubMed Web of Science ®Google Scholar
• Gardner MJ, Hall N, Fung E, Genome sequence of the human malaria parasite plasmodium falciparum. Nature 2002;419:498-511
   PubMed Web of Science ®Google Scholar
• Carlton JM, Adams JH, Silva JC, Comparative genomics of the neglected human malaria parasite plasmodium vivax. Nature 2008;455:757-63
   PubMed Web of Science ®Google Scholar
• Pain A, Bohme U, Berry AE, The genome of the simian and human malaria parasite plasmodium knowlesi. Nature 2008;455:799-803
   PubMed Web of Science ®Google Scholar
• Carlton JM, Angiuoli SV, Suh BB, Genome sequence and comparative analysis of the model rodent malaria parasite plasmodium yoelii yoelii. Nature 2002;419:512-9
   PubMed Web of Science ®Google Scholar
• Flower D. Bioinformatics for Vaccinology. Chichester, West Sussex, UK: John Wiley & Sons; 2008
   Google Scholar
• Hall N, Karras M, Raine JD, A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 2005;307:82-6
   PubMed Web of Science ®Google Scholar
• Sim BK, Chitnis CE, Wasniowska K, Receptor and ligand domains for invasion of erythrocytes by plasmodium falciparum. Science 1994;264:1941-4
   PubMed Web of Science ®Google Scholar
• Mu J, Awadalla P, Duan J, Genome-wide variation and identification of vaccine targets in the plasmodium falciparum genome. Nat Genet 2007;39:126-30
   PubMed Web of Science ®Google Scholar
• Doolan DL, Mu Y, Unal B, Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008;8:4680-94
   PubMed Web of Science ®Google Scholar
• Aguiar JC, LaBaer J, Blair PL, High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res 2004;14:2076-82
   PubMed Web of Science ®Google Scholar
• Mehlin C, Boni E, Buckner FS, Heterologous expression of proteins from plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol 2006;148:144-60
   PubMed Web of Science ®Google Scholar
• Vedadi M, Lew J, Artz J, Genome-scale protein expression and structural biology of plasmodium falciparum and related apicomplexan organisms. Mol Biochem Parasitol 2007;151:100-10
   PubMed Web of Science ®Google Scholar
• Gowda DC, Davidson EA. Protein glycosylation in the malaria parasite. Parasitol Today 1999;15:147-52
   PubMedGoogle Scholar
• Kedees MH, Azzouz N, Gerold P, Plasmodium falciparum: glycosylation status of plasmodium falciparum circumsporozoite protein expressed in the baculovirus system. Exp Parasitol 2002;101:64-8
   PubMed Web of Science ®Google Scholar
• Samuelson J, Banerjee S, Magnelli P, The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc Natl Acad Sci USA 2005;102:1548-53
   PubMed Web of Science ®Google Scholar
• Tsuboi T, Takeo S, Iriko H, Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 2008;76:1702-8
   PubMed Web of Science ®Google Scholar
• Madin K, Sawasaki T, Ogasawara T, A highly efficient and robust cell-free protein synthesis system prepared from wheat embryos: plants apparently contain a suicide system directed at ribosomes. Proc Natl Acad Sci USA 2000;97:559-64
   PubMed Web of Science ®Google Scholar
• Endo Y, Sawasaki T. Cell-free expression systems for eukaryotic protein production. Curr Opin Biotechnol 2006;17:373-80
   PubMed Web of Science ®Google Scholar
• Goshima N, Kawamura Y, Fukumoto A, Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat Methods 2008;5:1011-7
   PubMed Web of Science ®Google Scholar
• Sawasaki T, Ogasawara T, Morishita R, A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci USA 2002;99:14652-7
   PubMed Web of Science ®Google Scholar
• Sawasaki T, Endo Y. The wheat germ cell-free protein synthesis system. In: Spirin AS, Swartz JR, editors, Cell-free protein synthesis, methods and protocols. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2008. p. 111-39
   Google Scholar
• Sawasaki T, Gouda MD, Kawasaki T, The wheat germ cell-free expression system: methods for high-throughput materialization of genetic information. Methods Mol Biol 2005;310:131-44
   PubMedGoogle Scholar
• Kamura N, Sawasaki T, Kasahara Y, Selection of 5′-untranslated sequences that enhance initiation of translation in a cell-free protein synthesis system from wheat embryos. Bioorg Med Chem Lett 2005;15:5402-6
   PubMed Web of Science ®Google Scholar
• Vinarov DA, Lytle BL, Peterson FC, Cell-free protein production and labeling protocol for NMR-based structural proteomics. Nat Methods 2004;1:149-53
   PubMed Web of Science ®Google Scholar
• Mudeppa DG, Pang CK, Tsuboi T, Cell-free production of functional plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Mol Biochem Parasitol 2007;151:216-9
   PubMed Web of Science ®Google Scholar
• Takeo S, Hisamori D, Matsuda S, Enzymatic characterization of the plasmodium vivax chitinase, a potential malaria transmission-blocking target. Parasitol Int 2009:58;243-8
   PubMed Web of Science ®Google Scholar
• Maeda T, Saito T, Harb OS, Pyruvate kinase type-II isozyme in plasmodium falciparum localizes to the apicoplast. Parasitol Int 2009;58:101-5
   PubMed Web of Science ®Google Scholar
• VanBuskirk KM, O'Neill MT, De La Vega P, Preerythrocytic, live-attenuated plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci USA 2009: 106;13004-9
   PubMed Web of Science ®Google Scholar
• Cao J, Kaneko O, Thongkukiatkul A, Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in plasmodium falciparum merozoites. Parasitol Int 2009;58:29-35
   PubMed Web of Science ®Google Scholar
• Otsuki H, Kaneko O, Thongkukiatkul A, Single amino acid substitution in plasmodium yoelii erythrocyte ligand determines its localization and controls parasite virulence. Proc Natl Acad Sci USA 2009;106:7167-72
   PubMed Web of Science ®Google Scholar
• Dutta S, Lalitha PV, Ware LA, Purification, characterization, and immunogenicity of the refolded ectodomain of the plasmodium falciparum apical membrane antigen 1 expressed in escherichia coli. Infect Immun 2002;70:3101-10
   PubMed Web of Science ®Google Scholar
• Netzer WJ, Hartl FU. Recombination of protein domains facilitated by co-translational folding in eukaryotes. Nature 1997;388:343-9
   PubMed Web of Science ®Google Scholar
• Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 2002;295:1852-8
   PubMed Web of Science ®Google Scholar